| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Endocrinology, Diabetes, and Bone Diseases (B.G., L.L., Y.B., E.C., Y.T.), Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029; and Division of Statistical Genetics (D.A.G.), Columbia University, New York, New York 10032
Address all correspondence and requests for reprints to: Yaron Tomer, M.D., Division of Endocrinology, Diabetes, and Bone Diseases, Box 1055, Mount Sinai Medical Center, One Gustave L. Levy Place, New York, New York 10029. E-mail: Yaron.Tomer{at}mssm.edu.
Context: Epidemiological data suggest a common genetic susceptibility to type 1 diabetes (T1D) and autoimmune thyroid disease (AITD).
Objective: Our objective was to identify the joint susceptibility genes for T1D and AITD.
Design: We conducted a family-based linkage and association study.
Setting: The study took place at an academic medical center.
Participants: Participants included 55 multiplex families (290 individuals) in which T1D and AITD clustered (T1D-AITD families).
Main Outcome Measures: We conducted tests for linkage and family-based associations (transmission disequilibrium test) with four candidate genes: human leukocyte antigen (HLA), cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), insulin variable number of tandem repeats (VNTR), and thyroglobulin.
Results: Linkage evidence to HLA appeared when subjects with either T1D or AITD were considered affected [maximum LOD score (MLS), 2.2]. The major HLA haplotype contributing to the shared susceptibility was DR3-DQB1*0201, with DR3 conferring most of the shared risk. The CTLA-4 gene showed evidence for linkage only when individuals with both T1D and AITD were considered affected (MLS, 1.7), and the insulin VNTR showed evidence for linkage when individuals with either T1D or AITD were considered affected (MLS, 1.9); i.e. it may contribute to the familial aggregation of T1D and AITD.
Conclusions: The HLA class II locus contributes to the shared risk for T1D and AITD, and the major HLA haplotype contributing to this association is DR3-DQB1*0201. Additional non-HLA loci contribute to the joint susceptibility to T1D and AITD, and two potential candidates include the CTLA-4 and insulin VNTR loci.
This article has been cited by other articles:
![]() |
M. Dittmar, M. Ide, M. Wurm, and G. J Kahaly Early onset of polyglandular failure is associated with HLA-DRB1*03. Eur. J. Endocrinol., July 1, 2008; 159(1): 55 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsurumaru, E. Kawasaki, H. Ida, K. Migita, A. Moriuchi, K. Fukushima, T. Fukushima, N. Abiru, H. Yamasaki, S. Noso, et al. Evidence for the Role of Small Ubiquitin-Like Modifier 4 as a General Autoimmunity Locus in the Japanese Population J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3138 - 3143. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |